{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:05:21Z","timestamp":1774620321666,"version":"3.50.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The aim of the study was to determine the incidence of and risk factors for drug resistance of Streptococcus pneumoniae, and its impact on the outcome among hospitalized patients of pneumococcal pneumonia acquired in the community. Consecutive patients with culture-proven pneumococcal pneumonia were prospectively studied with regard to the incidence of pneumococcal drug resistance, potential risk factors, and in-hospital outcome variables. A total of 101 patients were studied. Drug resistance to penicillin, cephalosporin, or a macrolide drug was found in pneumococci from 52 of the 101 (52%) patients; 49% of these isolates were resistant to penicillin (16% intermediate resistance, 33% high resistance), 31% to cephalosporin (22% intermediate and 9% high resistance), and 27% to a macrolide drug. In immunocompetent patients, age &amp;gt; 65 yr was significantly associated with resistance to cephalosporin (odds ratio [OR]: 5.0; 95% confidence interval [CI]: 1.3 to 18.8, p = 0.01), and with the presence of &amp;gt; 2 comorbidities with resistance to penicillin (OR: 4.7; 95% CI: 1.2 to 19.1; p &amp;lt; 0.05). In immunosuppressed patients, bacteremia was inversely associated with resistance to penicillin and cephalosporin (OR: 0.04; 95% CI: 0.003 to 0.45; p &amp;lt; 0.005; and OR: 0.46; 95% CI: 0.23 to 0.93; p &amp;lt; 0.05, respectively). Length of hospital stay, severity of pneumonia, and complications were not significantly affected by drug resistance. Mortality was 15% in patients with any drug resistance, as compared with 6% in those without resistance. However, any drug resistance was not significantly associated with death (relative risk [RR]: 2.5; 95% CI: 0.7 to 8.9; p = 0.14). Moreover, attributable mortality in the presence of discordant antimicrobial treatment was 12%, as compared with 10% (RR: 1.2; 95% CI: 0.3 to 5.3; p = 0.67) in the absence of such treatment. We conclude that the incidence of drug-resistant pneumococci was high. Risk factors for drug resistance included advanced age, comorbidity, and (inversely) bacteremia. Outcome was not significantly affected by drug resistance.<\/jats:p>","DOI":"10.1164\/ajrccm.159.6.9808049","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T13:59:16Z","timestamp":1365083956000},"page":"1835-1842","source":"Crossref","is-referenced-by-count":139,"title":["Pneumonia Acquired in the Community Through Drug-Resistant\n                    <i>Streptococcus pneumoniae<\/i>"],"prefix":"10.1093","volume":"159","author":[{"given":"SANTIAGO","family":"EWIG","sequence":"first","affiliation":[{"name":"Serveis de Pneumologia i Al\u00b7l\u00e8rgia Respiratoria, Microbiologia, Malalties Infeccioces, Urgencies, Hospital Clinic, Departament de Medicina, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAURICIO","family":"RUIZ","sequence":"additional","affiliation":[{"name":"Serveis de Pneumologia i Al\u00b7l\u00e8rgia Respiratoria, Microbiologia, Malalties Infeccioces, Urgencies, Hospital Clinic, Departament de Medicina, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANTONI","family":"TORRES","sequence":"additional","affiliation":[{"name":"Serveis de Pneumologia i Al\u00b7l\u00e8rgia Respiratoria, Microbiologia, Malalties Infeccioces, Urgencies, Hospital Clinic, Departament de Medicina, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FRANCESC","family":"MARCO","sequence":"additional","affiliation":[{"name":"Serveis de Pneumologia i Al\u00b7l\u00e8rgia Respiratoria, Microbiologia, Malalties Infeccioces, Urgencies, Hospital Clinic, Departament de Medicina, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOSE ANTONIO","family":"MARTINEZ","sequence":"additional","affiliation":[{"name":"Serveis de Pneumologia i Al\u00b7l\u00e8rgia Respiratoria, Microbiologia, Malalties Infeccioces, Urgencies, Hospital Clinic, Departament de Medicina, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MIGUEL","family":"SANCHEZ","sequence":"additional","affiliation":[{"name":"Serveis de Pneumologia i Al\u00b7l\u00e8rgia Respiratoria, Microbiologia, Malalties Infeccioces, Urgencies, Hospital Clinic, Departament de Medicina, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOSEP","family":"MENSA","sequence":"additional","affiliation":[{"name":"Serveis de Pneumologia i Al\u00b7l\u00e8rgia Respiratoria, Microbiologia, Malalties Infeccioces, Urgencies, Hospital Clinic, Departament de Medicina, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,6,1]]},"reference":[{"key":"2026032709000386800_B1","first-page":"195","article-title":"Community-acquired pneumonia in adults in British hospitals in 1982\u2013 1983: a survey of aetiology, mortality, prognostic factors and outcome.","volume":"239","author":"British Thoracic Society and the Public Health Laboratory Service","year":"1987","journal-title":"Q. J. Med."},{"key":"2026032709000386800_B2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1183\/09031936.93.03101105","article-title":"Aetiology, outcome and prognostic factors in patients with community acquired pneumonia requiring hospitalisation.","volume":"3","author":"\u00d6rtquist","year":"1990","journal-title":"Eur. Respir. J."},{"key":"2026032709000386800_B3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00005792-199009000-00004","article-title":"New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases.","volume":"69","author":"Fang","year":"1990","journal-title":"Medicine"},{"key":"2026032709000386800_B4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/infdis\/162.5.1012","article-title":"The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents.","volume":"162","author":"Redd","year":"1990","journal-title":"J. Infect. Dis."},{"key":"2026032709000386800_B5","first-page":"2589","article-title":"Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection.","volume":"154","author":"Burack","year":"1994","journal-title":"Am. J. Med."},{"key":"2026032709000386800_B6","first-page":"350","article-title":"Prospective study of pneumonia hospitalizations and mortality of US older people: role of chronic conditions, health behaviours, and nutritional status.","volume":"104","author":"LaCroix","year":"1989","journal-title":"Public Health Rep."},{"key":"2026032709000386800_B7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/00365549509019009","article-title":"Severe community-acquired pneumonia.","volume":"27","author":"Moine","year":"1995","journal-title":"Scand. J. Infect. Dis."},{"key":"2026032709000386800_B8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/clinids\/15.1.77","article-title":"Antimicrobial resistance in Streptococcus pneumoniae: an overview.","volume":"15","author":"Appelbaum","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"2026032709000386800_B9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/mdr.1995.1.115","article-title":"Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview.","volume":"1","author":"Baquero","year":"1995","journal-title":"Microb. Drug Resist."},{"key":"2026032709000386800_B10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/clinids\/15.1.95","article-title":"Antimicrobial resistance in Streptococcus pneumoniae: an epidemioogical survey in France 1970\u20131990.","volume":"15","author":"Geslin","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"2026032709000386800_B11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/clinids\/22.1.63","article-title":"Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey.","volume":"22","author":"Bedos","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"2026032709000386800_B12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1056\/NEJM198707023170104","article-title":"Risk factors and response to antibiotic therapy in adults with bacterial pneumonia caused by penicillin-resistant pneumococci.","volume":"317","author":"Pallares","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"2026032709000386800_B13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/clinids\/13.1.56","article-title":"Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979\u20131989.","volume":"13","author":"Fenoll","year":"1991","journal-title":"Rev. Infect. Dis."},{"key":"2026032709000386800_B14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/clinids\/14.2.427","article-title":"Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study.","volume":"14","author":"Garcia-Leoni","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"2026032709000386800_B15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/clinids\/15.1.99","article-title":"Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979\u20131990).","volume":"15","author":"Linares","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"2026032709000386800_B16","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.","volume":"333","author":"Pallares","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"2026032709000386800_B17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1086\/513628","article-title":"Multivariate analysis of risk factors for infection due to penicllin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study.","volume":"24","author":"Clavo-Sanchez","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"2026032709000386800_B18","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/infdis\/163.6.1273","article-title":"Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979\u20131987.","volume":"163","author":"Spika","year":"1991","journal-title":"J. Infect. Dis."},{"key":"2026032709000386800_B19","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.1994.03510470035031","article-title":"Emergence of drug-resistant pneumococcal infections in the United States.","volume":"271","author":"Breiman","year":"1994","journal-title":"J.A.M.A."},{"key":"2026032709000386800_B20","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1128\/AAC.40.5.1208","article-title":"Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.","volume":"40","author":"Doern","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026032709000386800_B21"},{"key":"2026032709000386800_B22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/clinids\/22.3.437","article-title":"Risk factors for isolation of Streptococcus pneumoniae with decreased susceptibility to penicillin G from patients infected with human immunodeficiency virus.","volume":"22","author":"Meynard","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"2026032709000386800_B23","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"2026032709000386800_B24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0025-6196(25)09678-8","article-title":"Microscopic and bacteriologic analysis of expectorated sputum.","volume":"50","author":"Murray","year":"1975","journal-title":"Mayo Clin. Proc."},{"key":"2026032709000386800_B25"},{"key":"2026032709000386800_B26"},{"key":"2026032709000386800_B27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia.","volume":"336","author":"Fine","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"2026032709000386800_B28"},{"key":"2026032709000386800_B29","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/clinids\/19.5.884","article-title":"Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study.","volume":"19","author":"Nava","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"2026032709000386800_B30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00045413-199707000-00002","article-title":"The clinical relevance of antibiotic resistance in the management of pneumococcal pneumonia.","volume":"4","author":"Klugman","year":"1997","journal-title":"Clin. Pulm. Med."}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/159\/6\/1835\/67429236\/ajrccm_159_6_1835.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/159\/6\/1835\/67429236\/ajrccm_159_6_1835.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:00:09Z","timestamp":1774616409000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/159\/6\/1835\/8529971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6,1]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1999,6,1]]},"published-print":{"date-parts":[[1999,6,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.159.6.9808049","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1999,6]]},"published":{"date-parts":[[1999,6,1]]}}}